BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31151895)

  • 21. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
    Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
    Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
    Ullman T; Croog V; Harpaz N; Sachar D; Itzkowitz S
    Gastroenterology; 2003 Nov; 125(5):1311-9. PubMed ID: 14598247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.
    Bruewer M; Schmid KW; Krieglstein CF; Senninger N; Schuermann G
    World J Surg; 2002 Jun; 26(6):726-31. PubMed ID: 12053227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population.
    Kishikawa J; Hata K; Kazama S; Anzai H; Shinagawa T; Murono K; Kaneko M; Sasaki K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Morikawa T; Fukayama M; Watanabe T
    Dig Endosc; 2018 Mar; 30(2):236-244. PubMed ID: 28836702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme.
    Leidenius M; Kellokumpu I; Husa A; Riihelä M; Sipponen P
    Gut; 1991 Dec; 32(12):1521-5. PubMed ID: 1773959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysplasia in ulcerative colitis--clinical consequences?
    Sjöqvist U
    Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis.
    Ortner MA; Fusco V; Ebert B; Sukowski U; Weber-Eibel J; Fleige B; Stolte M; Oberhuber G; Rinneberg H; Lochs H
    Gastrointest Endosc; 2010 Feb; 71(2):312-8. PubMed ID: 20003972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pine-cone and villi patterns are endoscopic signs suggestive of ulcerative colitis-associated colorectal cancer and dysplasia.
    Shinagawa T; Hata K; Morikawa T; Takiyama H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Tanaka T; Kawai K; Fukayama M; Nozawa H
    Gastrointest Endosc; 2019 Mar; 89(3):565-575.e3. PubMed ID: 30326231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
    Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy.
    Kisiel JB; Loftus EV; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Inflamm Bowel Dis; 2012 Feb; 18(2):226-35. PubMed ID: 21416564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of a diagnosis of dysplasia in ulcerative colitis.
    Riddell RH
    J Gastroenterol; 1995 Nov; 30 Suppl 8():25-9. PubMed ID: 8563882
    [No Abstract]   [Full Text] [Related]  

  • 37. Postoperative Survival in Colitis-associated Colorectal Cancer With Ulcerative Colitis in Japan: A Multicenter Analysis.
    Sugita A; Ikeuchi H; Funayama Y; Futami K; Iiai T; Itabashi M; Suzuki Y
    Anticancer Res; 2021 May; 41(5):2681-2688. PubMed ID: 33952499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?
    Gorfine SR; Bauer JJ; Harris MT; Kreel I
    Dis Colon Rectum; 2000 Nov; 43(11):1575-81. PubMed ID: 11089596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-polypoid colorectal neoplasms in ulcerative colitis.
    Ueno Y; Tanaka S; Chayama K
    Gastrointest Endosc Clin N Am; 2010 Jul; 20(3):525-42. PubMed ID: 20656250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential diagnosis of dysplasia-associated lesion or mass and coincidental adenoma in ulcerative colitis.
    Suzuki K; Muto T; Shinozaki M; Yokoyama T; Matsuda K; Masaki T
    Dis Colon Rectum; 1998 Mar; 41(3):322-7. PubMed ID: 9514427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.